Proscia
Founded Year
2014Stage
Series B | AliveTotal Raised
$34.01MLast Raised
$23M | 1 yr agoAbout Proscia
Proscia is a software company focused on transforming cancer research and diagnosis. With the company's Concentriq digital pathology platform and pipeline of AI algorithms, laboratories are leveraging new kinds of data to improve patient outcomes and accelerate discoveries.
Proscia Headquarter Location
1700 Market Street 23rd Floor
Philadelphia, Pennsylvania, 19103,
United States
877-255-1341
Proscia's Products & Differentiation
See Proscia's products and how their products differentiate from alternatives and competitors
Concentriq
Concentriq is a unified pathology image and data management platform that marries enterprise scalability with powerful AI applications to help optimize operations, accelerate breakthroughs, and improve patient care. It offers the robust functionality that leading diagnostic laboratories, health systems, and life sciences organizations need to carry out their day-to-day pathology work, including viewing, managing, sharing, and analyzing images. Concentriq also serves as a launchpad for AI applications from Proscia, our customers, and other third parties, allowing organizations to seamlessly deploy them into routine practice. In doing so, Concentriq centralizes pathology operations and serves as the center of gravity for the organization.
Subscribe to see more
We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.
Research containing Proscia
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Proscia in 5 CB Insights research briefs, most recently on Aug 4, 2021.
Expert Collections containing Proscia
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Proscia is included in 7 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
8,694 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Digital Health 150
150 items
2019's cohort of the most promising digital health startups transforming the healthcare industry
Medical Devices
8,325 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Health Monitoring & Diagnostics
2,707 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health
12,795 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Proscia Patents
Proscia has filed 8 patents.
The 3 most popular patent topics include:
- Epidermal nevi, neoplasms, cysts
- Machine learning
- Artificial neural networks
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/17/2016 | 4/7/2020 | Cloud storage, Microscopy, Network topology, Biological research institutes, Pathology | Grant |
Application Date | 3/17/2016 |
|---|---|
Grant Date | 4/7/2020 |
Title | |
Related Topics | Cloud storage, Microscopy, Network topology, Biological research institutes, Pathology |
Status | Grant |
Latest Proscia News
Mar 23, 2022
Proscia, a digital and computational pathology solutions specialist, has announced a multi-year OEM agreement with Siemens Healthineers.
Proscia Web Traffic
Proscia Rank
You May Also Like
Paige delivers AI-powered digital diagnostics and biomarkers for pathologists, oncologists, and the R&D community worldwide, while also working closely with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The firm's target customers include pathologists, hospital leads/chairs as well as life sciences research and translational teams.
PathAI provides AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.
TRIBVN Healthcare supports the digital transformation of cancer diagnosis by designing innovative solutions. These solutions enable the management, analysis and sharing of cellular images for both diagnostic laboratories and pharmaceutical and biotech companies. The company offers customized support in digital pathology, focused on the customer’s expectations.
Ibex Medical Analytics develops AI-driven clinical decision support tools that help pathologists deliver more efficient, metric-driven, objective and accurate diagnosis. Ibex develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to confirm cancer diagnoses of tissue biopsies. The company was founded in 2016 and is based in Israel.
Qritive is developing clinical-grade decision support systems to enhance histopathology diagnosis of cancer and to assist doctors in delivering insightful and personalized care to patients. The company has developed Pantheon, a CE marked vendor-agnostic digital pathology platform that enables digitization of the entire pathology lab workflow and telepathology, supports rich report generation, and provides a platform for AI analysis of pathology whole-slide images.
Deciphex focuses on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.